DUBLIN, July 4, 2022 /PRNewswire/ — The “Global Digital Therapeutic (DTx) Market (2022-2027) by Component, Indication, Distribution, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.
The Global Digital Therapeutic (DTx) Market is estimated to be USD 12.84 Bn in 2022 and is projected to reach USD 47.93 Bn by 2027, growing at a CAGR of 30.14%. Market Dynamics
Market dynamics are forces that impact the prices and behaviors of the Global Digital Therapeutic (DTx) Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.
Company Profiles
The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies’ recent development and competitive scenario. Some of the companies covered in this report are 2Morrow, Akili Interactive Labs, Ayogo Health, Better Therapeutics, BigHealth, Canary Health, Click Therapeutics, Cognoa, Ginger, Happify, Kaia Health, Omada Health, Welldoc, etc. Countries Studied
- America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
- Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
- Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
- Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.Ansoff Analysis
- The report presents a detailed Ansoff matrix analysis for the Global Digital Therapeutic (DTx) Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
- The report analyses the Global Digital Therapeutic (DTx) Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
- Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.
Why buy this report?
- The report offers a comprehensive evaluation of the Global Digital Therapeutic (DTx) Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
- The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report also contains the competitive analysis using Positioning Quadrants, the analyst’s Proprietary competitive positioning tool.
Key Topics Covered: 1 Report Description2 Research Methodology3 Executive Summary4 Market Dynamics4.1 Drivers4.1.1 Increasing Incidence of Preventable Chronic Diseases4.1.2 Increasing mHealth Penetration4.1.3 Control on Healthcare Cost with Focus on Preventive Healthcare4.2 Restraints4.2.1 Limited Awareness Regarding Digital Therapeutics in the Developing Countries4.3 Opportunities4.3.1 Huge Undiagnosed and Untreated Population Base4.3.2 R & D in Therapeutic Applications4.4 Challenges4.4.1 Patient Data Privacy Concerns4.4.2 Reluctance among Patients to adopt Digital Therapeutics5 Market Analysis5.1 Regulatory Scenario5.2 Porter’s Five Forces Analysis5.3 Impact of COVID-195.4 Ansoff Matrix Analysis 6 Global Digital Therapeutic (DTx) Market, By Component6.1 Introduction6.2 Devices6.3 Software7 Global Digital Therapeutic (DTx) Market, By Indication7.1 Introduction7.2 Cardiovascular Disease7.3 Central Nervous System Disorder7.4 Chronic Respiratory Disease7.5 Diabetes7.6 Medication Adherence7.7 Musculoskeletal Disorder7.8 Obesity7.9 Smoking Cessation8 Global Digital Therapeutic (DTx) Market, By Distribution8.1 Introduction8.2 B2B8.2.1 Employer8.2.2 Payer8.2.3 Pharmaceutical Company8.2.4 Provider8.3 B2C8.3.1 Caregiver8.3.2 Patient9 Americas’ Digital Therapeutic (DTx) Market9.1 Introduction9.2 Argentina9.3 Brazil9.4 Canada9.5 Chile9.6 Colombia9.7 Mexico9.8 Peru9.9 United States9.10 Rest of Americas10 Europe’s Digital Therapeutic (DTx) Market10.1 Introduction10.2 Austria10.3 Belgium10.4 Denmark10.5 Finland10.6 France10.7 Germany10.8 Italy10.9 Netherlands10.10 Norway10.11 Poland10.12 Russia10.13 Spain10.14 Sweden10.15 Switzerland10.16 United Kingdom10.17 Rest of Europe11 Middle East and Africa’s Digital Therapeutic (DTx) Market11.1 Introduction11.2 Egypt11.3 Israel11.4 Qatar11.5 Saudi Arabia11.6 South Africa11.7 United Arab Emirates11.8 Rest of MEA12 APAC’s Digital Therapeutic (DTx) Market12.1 Introduction12.2 Australia12.3 Bangladesh12.4 China12.5 India12.6 Indonesia12.7 Japan12.8 Malaysia12.9 Philippines12.10 Singapore12.11 South Korea12.12 Sri Lanka12.13 Thailand12.14 Taiwan12.15 Rest of Asia-Pacific 13 Competitive Landscape13.1 Competitive Quadrant13.2 Market Share Analysis13.3 Strategic Initiatives13.3.1 M&A and Investments13.3.2 Partnerships and Collaborations13.3.3 Product Developments and Improvements14 Company Profiles14.1 2Morrow 14.2 Akili Interactive Labs14.3 Ayogo Health 14.4 Better Therapeutics14.5 BigHealth14.6 Canary Health 14.7 Click Therapeutics14.8 Cognoa14.9 Ginger14.10 Happify14.11 Kaia Health 14.12 Omada Health14.13 Welldoc15 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/2dza2u
Media Contact:
Research and Markets Laura Wood, Senior Manager [email protected]
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
Logo: http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/the-worldwide-digital-therapeutic-dtx-industry-is-expected-to-reach-47-9-by-2027–301580175.html
SOURCE Research and Markets
Disclaimer: The above press release comes to you under an arrangement with PR Newswire. TheTechOutlook.com takes no editorial responsibility for the same.
